Extracellular Vesicles As a New Horizon in the Diagnosis and Treatment of Inflammatory Eye Diseases: A Narrative Review of the Literature

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2023 Mar 27

PMID 36969177

Authors

Azam Habibi

Zeinab Zarei-Behjani

Kimia Falamarzi

Mahdi Malekpour

Fatemeh Ebrahimi

Masood Soleimani

Mahmood Nejabat

Amir Khosravi

Zahra Moayedfard

Sara Pakbaz

Niloofar Dehdari Ebrahimi

Negar Azarpira

Affiliations

Soon will be listed here.

Abstract

Extracellular vesicles include exosomes, microvesicles, and apoptotic bodies. Their cargos contain a diverse variety of lipids, proteins, and nucleic acids that are involved in both normal physiology and pathology of the ocular system. Thus, studying extracellular vesicles may lead to a more comprehensive understanding of the pathogenesis, diagnosis, and even potential treatments for various diseases. The roles of extracellular vesicles in inflammatory eye disorders have been widely investigated in recent years. The term "inflammatory eye diseases" refers to a variety of eye conditions such as inflammation-related diseases, degenerative conditions with remarkable inflammatory components, neuropathy, and tumors. This study presents an overview of extracellular vesicles' and exosomes' pathogenic, diagnostic, and therapeutic values in inflammatory eye diseases, as well as existing and potential challenges.

Citing Articles

Injective hydrogel encapsulating dental pulp stem cells for the treatment of traumatic optic nerve injury.

Luo L, Xing Z, Li Y, Wang B, Dong N, Sun J Front Bioeng Biotechnol. 2025; 13:1528749.

PMID: 40070549 PMC: 11893850. DOI: 10.3389/fbioe.2025.1528749.

Proteomic Characterization of Corneal Epithelial and Stromal Cell-Derived Extracellular Vesicles.

Yeung V, Boychev N, Kanu L, Ng V, Ross A, Hutcheon A Int J Mol Sci. 2024; 25(19).

PMID: 39408670 PMC: 11477500. DOI: 10.3390/ijms251910338.

References

Zhang W, Dong X, Wang T, Kong Y . Exosomes derived from platelet-rich plasma mediate hyperglycemia-induced retinal endothelial injury via targeting the TLR4 signaling pathway. Exp Eye Res. 2019; 189:107813. DOI: 10.1016/j.exer.2019.107813. View

Taylor A . Ocular Immune Privilege and Transplantation. Front Immunol. 2016; 7:37. PMC: 4744940. DOI: 10.3389/fimmu.2016.00037. View

Aqrawi L, Galtung H, Vestad B, Ovstebo R, Thiede B, Rusthen S . Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis. Arthritis Res Ther. 2017; 19(1):14. PMC: 5264463. DOI: 10.1186/s13075-017-1228-x. View

Nikolov N, Illei G . Pathogenesis of Sjögren's syndrome. Curr Opin Rheumatol. 2009; 21(5):465-70. PMC: 2766246. DOI: 10.1097/BOR.0b013e32832eba21. View

Hirschberger S, Hinske L, Kreth S . MiRNAs: dynamic regulators of immune cell functions in inflammation and cancer. Cancer Lett. 2018; 431:11-21. DOI: 10.1016/j.canlet.2018.05.020. View

Castiblanco C, Foster C . Review of Systemic Immunosuppression for Autoimmune Uveitis. Ophthalmol Ther. 2014; 3(1-2):17-36. PMC: 4254861. DOI: 10.1007/s40123-014-0023-x. View

Lande K, Gupta J, Ranjan R, Kiran M, Solis L, Herrera A . Exosomes: Insights from Retinoblastoma and Other Eye Cancers. Int J Mol Sci. 2020; 21(19). PMC: 7582726. DOI: 10.3390/ijms21197055. View

Platania C, Maisto R, Trotta M, DAmico M, Rossi S, Gesualdo C . Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach. Br J Pharmacol. 2019; 176(13):2179-2194. PMC: 6555853. DOI: 10.1111/bph.14665. View

Kaur G, Singh N . Inflammation and retinal degenerative diseases. Neural Regen Res. 2022; 18(3):513-518. PMC: 9727454. DOI: 10.4103/1673-5374.350192. View

10.

Gordon L . Orbital inflammatory disease: a diagnostic and therapeutic challenge. Eye (Lond). 2006; 20(10):1196-206. DOI: 10.1038/sj.eye.6702383. View

11.

Shen T, Zheng Q, Shen J, Li Q, Song X, Luo H . Effects of Adipose-derived Mesenchymal Stem Cell Exosomes on Corneal Stromal Fibroblast Viability and Extracellular Matrix Synthesis. Chin Med J (Engl). 2018; 131(6):704-712. PMC: 5865317. DOI: 10.4103/0366-6999.226889. View

12.

Guo J, Wang F, Hu Y, Luo Y, Wei Y, Xu K . Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases. Cell Rep Med. 2023; 4(1):100881. PMC: 9873828. DOI: 10.1016/j.xcrm.2022.100881. View

13.

Ji J, Sundquist J, Sundquist K . Gender-specific incidence of autoimmune diseases from national registers. J Autoimmun. 2016; 69:102-6. DOI: 10.1016/j.jaut.2016.03.003. View

14.

Surman M, Stepien E, PRZYBYlO M . Melanoma-Derived Extracellular Vesicles: Focus on Their Proteome. Proteomes. 2019; 7(2). PMC: 6630787. DOI: 10.3390/proteomes7020021. View

15.

Zheng H, Yang F, Ea V, Zhou L, Wu L, Zhao G . Proteomics Profiling of Plasma Exosomes in VKH Patients. Curr Mol Med. 2020; 21(8):675-689. DOI: 10.2174/1566524020666200719021653. View

16.

Ma S, Liu X, Yin J, Hao L, Diao Y, Zhong J . Exosomes and autophagy in ocular surface and retinal diseases: new insights into pathophysiology and treatment. Stem Cell Res Ther. 2022; 13(1):174. PMC: 9066793. DOI: 10.1186/s13287-022-02854-8. View

17.

Shojaati G, Khandaker I, Funderburgh M, Mann M, Basu R, Stolz D . Mesenchymal Stem Cells Reduce Corneal Fibrosis and Inflammation via Extracellular Vesicle-Mediated Delivery of miRNA. Stem Cells Transl Med. 2019; 8(11):1192-1201. PMC: 6811691. DOI: 10.1002/sctm.18-0297. View

18.

Vujosevic S, Aldington S, Silva P, Hernandez C, Scanlon P, Peto T . Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol. 2020; 8(4):337-347. DOI: 10.1016/S2213-8587(19)30411-5. View

19.

Jeong D, Jo W, Yoon J, Kim J, Gianchandani S, Gho Y . Nanovesicles engineered from ES cells for enhanced cell proliferation. Biomaterials. 2014; 35(34):9302-10. DOI: 10.1016/j.biomaterials.2014.07.047. View

20.

Chen N, Wang J, Hu Y, Cui B, Li W, Xu G . MicroRNA-410 reduces the expression of vascular endothelial growth factor and inhibits oxygen-induced retinal neovascularization. PLoS One. 2014; 9(4):e95665. PMC: 4002426. DOI: 10.1371/journal.pone.0095665. View